( January 7, 2025, 1:05 PM EST) -- WASHINGTON, D. C. — The Federal Trade Commission on Jan. 6 announced a refund process for consumers who purchased treatment plans for COVID-19, cancer and Parkinson’s disease, which the FTC says were deceptively marketed by Golden Sunrise Nutraceutical Inc. ; some of them were priced at as much as $200,000. . . .